Whalesbook
Pharma ka 'Ammonia Stress'!
Yaar, government ki taraf se ek naya advisory aaya hai jo pharma sector ke liye thodi dikkat wali baat hai. Abse urea plants ka surplus ammonia sirf fertilizer production ke liye use hoga, woh bhi un manufacturers ke liye jinko subsidy milti hai. Ye sab natural gas ko fertilizer plants ko priority dene wale March 9 ke order ka hi part hai. Pharmexcil ke Chairman Namit Joshi ne kaha hai ki isse pharma sector mein ammonia ki kami ho sakti hai. Aur ye news tab aayi hai jab Nifty Pharma index toh 52-week high par pahunch gaya tha, jismein bada reason APIs ke badhte daam aur supply chain ki problems thi.
Pharma ko Ammonia kyun chahiye?
Aisa hai ki ammonia bahut saare APIs, intermediates aur dawa banane ke liye ek basic ingredient hai. Jab ammonia fertilizers mein jayega, toh pharma companies ke liye scarcity aur price hike dono ka khatra hai. Upper se pehle se hi freight, insurance sab kuch badh gaya hai, jis se March 2026 tak API costs lagbhag 30% tak badh chuki hain. India duniya mein teesre number par API banata hai aur 50% global demand poori karta hai, par agar basic cheezon ki supply mein problem hogi toh mushkil hai.
Regulatory Risk ka Side Effect
Ye situation dikha rahi hai ki hamara pharma sector kuch basic chemicals par kitna depend karta hai jinki allocation government policy ke hisab se change ho sakti hai. India ke API makers ko ammonia jaisi cheezein urea production se milti hain, aur ab agar wo fertilizer mein use hone lagi toh sourcing mein badi gap aa sakti hai. Pehle bhi Pharmexcil ne propylene, methanol aur ammonia jaise chemicals ki inventory kam hone ki baat kahi thi. Natural Gas (Supply Regulation) Order, 2026 ke hisab se 70% gas fertilizer plants ke liye hai, matlab pharma inputs ko priority list mein neeche rakha gaya hai. Agar ammonia reliable nahi raha ya bahut mehenga ho gaya toh India ki 'pharmacy of the world' wali image par bhi asar pad sakta hai.
Aage Kya Hai Outlook?
Analysts ka kehna hai ki FY26 mein pharma sector ka revenue toh lagbhag 12% badhega, par net profit 14% kam ho sakta hai, mainly input costs badhne ki wajah se. Ye ammonia wala rule abhi aur uncertainty badha raha hai. Haan, India green ammonia capacity par kaam kar raha hai, par abhi filhal current production ke liye ammonia milna sabse badi chinta hai. Divi's Laboratories, Sun Pharmaceutical Industries, aur Dr. Reddy's Laboratories jaise bade players pehle se hi high valuations par hain, toh unki profit margins par rise in input costs ka seedha asar padega.